CRL4CDT2 Targets CHK1 for PCNA-Independent Destruction

Molecular and Cellular Biology

Volumn 33, Issue 2, 2013, Pages 213-226

  Huh, Jiwon ^a   Piwnica Wormsa, Helen ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CDT2 PROTEIN; CHECKPOINT KINASE 1; CRL4 PROTEIN; CULLIN; CYCLINE; PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CHROMATIN; G2 PHASE CELL CYCLE CHECKPOINT; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; UBIQUITINATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; CELL CYCLE CHECKPOINTS; CELL CYCLE PROTEINS; CELL FRACTIONATION; CHROMATIN; CULLIN PROTEINS; DNA REPLICATION; GENE EXPRESSION REGULATION; HELA CELLS; HUMANS; IMMUNOPRECIPITATION; NUCLEAR PROTEINS; PLASMIDS; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTEIN BINDING; PROTEIN KINASES; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION;

EID: 84871905109     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00847-12     Document Type: Article

References (68)

1. Sorensen CS, Syluasen RG, Falck J, Schroeder T, Ronnstrand L, Khanna KK, Zhou B-B, Bartek J, Lukas J. 2003. Chk1 regulates the S phase checkpoint by coupling the physiological turnover and ionizing radiationinduced accelerated proteolysis of Cdc25A. Cancer Cell 3:247-258.
2. Zhao H, Watkins JL, Piwnica-Worms H. 2002. Disruption of the checkpoint kinase 1/cell division cycle 25A pathway abrogates ionizing radiation- induced S and G2 checkpoints. Proc. Natl. Acad. Sci. U. S. A. 99:14795-14800.
3. Smits VA, Warmerdam DO, Martin Y, Freire R. 2010. Mechanisms of ATR-mediated checkpoint signalling. Front. Biosci. 15:840-853.
4. Stracker TH, Usui T, Petrini JH. 2009. Taking the time to make important decisions: the checkpoint effector kinases Chk1 and Chk2 and the DNA damage response. DNA Repair (Amst.) 8:1047-1054.
5. Cortez D, Guntuku S, Qin J, Elledge SJ. 2001. ATR and ATRIP: partners in checkpoint signaling. Science 294:1713-1716.
6. Kumagai A, Kim SM, Dunphy WG. 2004. Claspin and the activated form of ATR-ATRIP collaborate in the activation of Chk1. J. Biol. Chem. 279:49599-49608.
7. Sorensen CS, Syljuasen RG, Lukas J, Bartek J. 2004. ATR, Claspin and the Rad9-Rad1-Hus1 complex regulate Chk1 and Cdc25A in the absence of DNA damage. Cell Cycle 3:941-945.
8. Yang XH, Zou L. 2006. Recruitment of ATR-ATRIP, Rad17, and 9-1-1 complexes to DNA damage. Methods Enzymol. 409:118-131.
9. Zou L, Elledge SJ. 2003. Sensing DNA damage through ATRIP recognition of RPA-ssDNA complexes. Science 300:1542-1548.
10. Clarke CA, Clarke PR. 2005. DNA-dependent phosphorylation of Chk1 and Claspin in a human cell-free system. Biochem. J. 388:705-712.
11. Liu Q, Guntuku S, Cui XS, Matsuoka S, Cortez D, Tamai K, Luo G, Carattini-Rivera S, DeMayo F, Bradley A, Donehower LA, Elledge SJ.2000. Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint. Genes Dev. 14:1448-1459.
12. Walworth NC, Bernards R. 1996. rad-dependent responses of the chk1-encoded protein kinase at the DNA damage checkpoint. Science 271:353-356.
13. Zhao H, Piwnica-Worms H. 2001. ATR-mediated checkpoint pathways regulate phosphorylation and activation of human Chk1. Mol. Cell. Biol.21:4129-4139.
14. Smits VA, Reaper PM, Jackson SP. 2006. Rapid PIKK-dependent release of Chk1 from chromatin promotes the DNA-damage checkpoint response. Curr. Biol. 16:150-159.
15. Leung-Pineda V, Huh J, Piwnica-Worms H. 2009. DDB1 targets Chk1 to the Cul4 E3 ligase complex in normal cycling cells and in cells experiencing replication stress. Cancer Res. 69:2630-2637.
16. Zhang YW, Brognard J, Coughlin C, You Z, Dolled-Filhart M, Aslanian A, Manning G, Abraham RT, Hunter T. 2009. The F box protein Fbx6 regulates Chk1 stability and cellular sensitivity to replication stress. Mol.Cell 35:442-453.
17. Zhang YW, Otterness DM, Chiang GG, Xie W, Liu YC, Mercurio F,Abraham RT. 2005. Genotoxic stress targets human Chk1 for degradation by the ubiquitin-proteasome pathway. Mol. Cell 19:607-618.
18. Petroski MD, Deshaies RJ. 2005. Function and regulation of cullin-RING ubiquitin ligases. Nat. Rev. Mol. Cell Biol. 6:9-20.
19. Angers S, Li T, Yi X, MacCoss MJ, Moon RT, Zheng N. 2006. Molecular architecture and assembly of the DDB1-CUL4A ubiquitin ligase machinery. Nature 443:590-593.
20. He YJ, McCall CM, Hu J, Zeng Y, Xiong Y. 2006. DDB1 functions as a linker to recruit receptor WD40 proteins to CUL4-ROC1 ubiquitin ligases.Genes Dev. 20:2949-2954.
21. Higa LA, Wu M, Ye T, Kobayashi R, Sun H, Zhang H. 2006. CUL4-DDB1 ubiquitin ligase interacts with multiple WD40-repeat proteins and regulates histone methylation. Nat. Cell Biol. 8:1277-1283.
22. Fukumoto Y, Dohmae N, Hanaoka F. 2008. Schizosaccharomyces pombe Ddb1 recruits substrate-specific adaptor proteins through a novel protein motif, the DDB-box. Mol. Cell. Biol. 28:6746-6756.
23. Jin J, Arias EE, Chen J, Harper JW, Walter JC. 2006. A family of diverse Cul4-Ddb1-interacting proteins includes Cdt2, which is required for S phase destruction of the replication factor Cdt1. Mol. Cell 23:709-721.
24. Havens CG, Walter JC. 2009. Docking of a specialized PIP box onto chromatin-bound PCNA creates a degron for the ubiquitin ligase CRL4Cdt2. Mol. Cell 35:93-104.
25. Teer JK, Dutta A. 2008. Human Cdt1 lacking the evolutionarily conserved region that interacts with MCM2-7 is capable of inducing rereplication. J. Biol. Chem. 283:6817-6825.
26. Lovly CM, Yan L, Ryan CE, Takada S, Piwnica-Worms H. 2008. Regulation of Chk2 ubiquitination and signaling through autophosphorylation of serine 379. Mol. Cell Biol. 28:5874-5885.
27. Wang QE, Zhu Q, Wani G, Chen J, Wani AA. 2004. UV radiationinduced XPC translocation within chromatin is mediated by damaged- DNA binding protein, DDB2. Carcinogenesis 25:1033-1043.
28. Abramoff MD, Magelhaes PJ, Ram SJ. 2004. Image processing with Image J. Biophotonics Int. 11:36-42.
29. Chen P, Luo C, Deng Y, Ryan K, Register J, Margosiak S, Tempczyk-Russell A, Nguyen B, Myers P, Lundgren K, Kan CC, O'Connor PM.2000. The 1.7 A crystal structure of human cell cycle checkpoint kinase Chk1: implications for Chk1 regulation. Cell 100:681-692.
30. Chen Y, Caldwell JM, Pereira E, Baker RW, Sanchez Y. 2009. ATRMec1 phosphorylation-independent activation of Chk1 in vivo. J. Biol. Chem.284:182-190.
31. Abbas T, Shibata E, Park J, Jha S, Karnani N, Dutta A. 2010.CRL4(Cdt2) regulates cell proliferation and histone gene expression by targeting PR-Set7/Set8 for degradation. Mol. Cell 40:9-21.
32. Abbas T, Sivaprasad U, Terai K, Amador V, Pagano M, Dutta A. 2008.PCNA-dependent regulation of p21 ubiquitylation and degradation via the CRL4Cdt2 ubiquitin ligase complex. Genes Dev. 22:2496-2506.
33. Centore RC, Havens CG, Manning AL, Li JM, Flynn RL, Tse A, Jin J,Dyson NJ, Walter JC, Zou L. 2010. CRL4(Cdt2)-mediated destruction of the histone methyltransferase Set8 prevents premature chromatin compaction in S phase. Mol. Cell 40:22-33.
34. Higa LA, Banks D, Wu M, Kobayashi R, Sun H, Zhang H. 2006.L2DTL/CDT2 interacts with the CUL4/DDB1 complex and PCNA and regulates CDT1 proteolysis in response to DNA damage. Cell Cycle 5:1675-1680.
35. Jorgensen S, Eskildsen M, Fugger K, Hansen L, Larsen MS, Kousholt AN, Syljuasen RG, Trelle MB, Jensen ON, Helin K, Sorensen CS. 2011.SET8 is degraded via PCNA-coupled CRL4(CDT2) ubiquitylation in S phase and after UV irradiation. J. Cell Biol. 192:43-54.
36. Kim Y, Starostina NG, Kipreos ET. 2008. The CRL4Cdt2 ubiquitin ligase targets the degradation of p21Cip1 to control replication licensing. Genes Dev. 22:2507-2519.
37. Nishitani H, Shiomi Y, Iida H, Michishita M, Takami T, Tsurimoto T.2008. CDK inhibitor p21 is degraded by a proliferating cell nuclear antigen- coupled Cul4-DDB1Cdt2 pathway during S phase and after UV irradiation.J. Biol. Chem. 283:29045-29052.
38. Oda H, Hubner MR, Beck DB, Vermeulen M, Hurwitz J, Spector DL,Reinberg D. 2010. Regulation of the histone H4 monomethylase PR-Set7 by CRL4(Cdt2)-mediated PCNA-dependent degradation during DNA damage. Mol. Cell 40:364-376.
39. Ralph E, Boye E, Kearsey SE. 2006. DNA damage induces Cdt1 proteolysis in fission yeast through a pathway dependent on Cdt2 and Ddb1.EMBO Rep. 7:1134-1139.
40. Sansam CL, Shepard JL, Lai K, Ianari A, Danielian PS, Amsterdam A,Hopkins N, Lees JA. 2006. DTL/CDT2 is essential for both CDT1 regulation and the early G2/M checkpoint. Genes Dev. 20:3117-3129.
41. Tardat M, Brustel J, Kirsh O, Lefevbre C, Callanan M, Sardet C, Julien E. 2010. The histone H4 Lys 20 methyltransferase PR-Set7 regulates replication origins in mammalian cells. Nat. Cell Biol. 12:1086-1093.
42. Ma CX, Janetka JW, Piwnica-Worms H. 2011. Death by releasing the breaks: CHK1 inhibitors as cancer therapeutics. Trends Mol. Med. 17:88-96.
43. Jeong SY, Kumagai A, Lee J, Dunphy WG. 2003. Phosphorylated claspin interacts with a phosphate-binding site in the kinase domain of Chk1 during ATR-mediated activation. J. Biol. Chem. 278:46782-46788.
44. Braun S, Garcia JF, Rowley M, Rougemaille M, Shankar S, Madhani HD. 2011. The Cul4-Ddb1(Cdt)(2) ubiquitin ligase inhibits invasion of a boundary-associated antisilencing factor into heterochromatin. Cell 144:41-54.
45. Li Y, Jaramillo-Lambert A, Hao J, Yang Y, Zhu W. 2011. The stability of histone acetyltransferase general control non-derepressible (Gcn) 5 is regulated by Cullin4-RING E3 ubiquitin ligase. J. Biol. Chem. 286:41344-41352.
46. Liu C, Poitelea M, Watson A, Yoshida SH, Shimoda C, Holmberg C,Nielsen O, Carr AM. 2005. Transactivation of Schizosaccharomyces pombe cdt2+ stimulates a Pcu4-Ddb1-CSN ubiquitin ligase. EMBO J.24:3940-3951.
47. Arias EE, Walter JC. 2006. PCNA functions as a molecular platform to trigger Cdt1 destruction and prevent re-replication. Nat. Cell Biol.8:84-90.
48. Senga T, Sivaprasad U, Zhu W, Park JH, Arias EE, Walter JC, Dutta A.2006. PCNA is a cofactor for Cdt1 degradation by CUL4/DDB1-mediated N-terminal ubiquitination. J. Biol. Chem. 281:6246-6252.
49. Scorah J, Dong MQ, Yates JR III, Scott M, Gillespie D, McGowan CH.2008. A conserved proliferating cell nuclear antigen-interacting protein sequence in Chk1 is required for checkpoint function. J. Biol. Chem. 283:17250-17259.
50. Havens CG, Shobnam N, Guarino E, Centore RC, Zou L, Kearsey SE,Walter JC. 2012. Direct role for proliferating cell nuclear antigen (PCNA) in substrate recognition by the E3 ubiquitin ligase CRL4-Cdt2. J. Biol.Chem. 287:11410-11421.
51. Raman M, Havens CG, Walter JC, Harper JW. 2011. A genome-wide screen identifies p97 as an essential regulator of DNA damage-dependent CDT1 destruction. Mol. Cell 44:72-84.
52. Rapic-Otrin V, McLenigan MP, Bisi DC, Gonzalez M, Levine AS. 2002. Sequential binding ofUVDNAdamage binding factor and degradation of the p48 subunit as early events after UV irradiation. Nucleic Acids Res.30:2588-2598.
53. Zabludoff SD, Deng C, Grondine MR, Sheehy AM, Ashwell S, Caleb BL,Green S, Haye HR, Horn CL, Janetka JW, Liu D, Mouchet E, Ready S, Rosenthal JL, Queva C, Schwartz GK, Taylor KJ, Tse AN, Walker GE, White AM. 2008. AZD7762, a novel checkpoint kinase inhibitor, drives checkpoint abrogation and potentiates DNA-targeted therapies. Mol.Cancer Ther. 7:2955-2966.
54. Li X, Zhao Q, Liao R, Sun P, Wu X. 2003. The SCF(Skp2) ubiquitin ligase complex interacts with the human replication licensing factor Cdt1 and regulates Cdt1 degradation. J. Biol. Chem. 278:30854-30858.
55. Yin Y, Yu VC, Zhu G, Chang DC. 2008. SET8 plays a role in controlling G1/S transition by blocking lysine acetylation in histone through binding to H4 N-terminal tail. Cell Cycle 7:1423-1432.
56. Yu ZK, Gervais JL, Zhang H. 1998. Human CUL-1 associates with the SKP1/SKP2 complex and regulates p21(CIP1/WAF1) and cyclin D proteins.Proc. Natl. Acad. Sci. U. S. A. 95:11324-11329.
57. Nishitani H, Sugimoto N, Roukos V, Nakanishi Y, Saijo M, Obuse C, Tsurimoto T, Nakayama KI, Nakayama K, Fujita M, Lygerou Z, Nishimoto T. 2006. Two E3 ubiquitin ligases, SCF-Skp2 and DDB1-Cul4,target human Cdt1 for proteolysis. EMBO J. 25:1126-1136.
58. Takeda DY, Parvin JD, Dutta A. 2005. Degradation of Cdt1 during S phase is Skp2-independent and is required for efficient progression of mammalian cells through S phase. J. Biol. Chem. 280:23416-23423.
59. Rosner M, Hanneder M, Siegel N, Valli A, Fuchs C, Hengstschlager M.2009. Skp2 inversely correlates with p27 and tuberin in transformed cells.Amino Acids 37:257-262.
60. Greenow KR, Clarke AR, Jones RH. 2009. Chk1 deficiency in the mouse small intestine results in p53-independent crypt death and subsequent intestinal compensation. Oncogene 28:1443-1453.
61. Lam MH, Liu Q, Elledge SJ, Rosen JM. 2004. Chk1 is haploinsufficient for multiple functions critical to tumor suppression. Cancer Cell 6:45-59.
62. Takai H, Tominaga K, Motoyama N, Minamishima YA, Nagahama H,Tsukiyama T, Ikeda K, Nakayama K, Nakanishi M, Nakayama K. 2000.Aberrant cell cycle checkpoint function and early embryonic death in Chk1(-/-) mice. Genes Dev. 14:1439-1447.
63. Zaugg K, Su YW, Reilly PT, Moolani Y, Cheung CC, Hakem R, Hirao A, Liu Q, Elledge SJ, Mak T.W. 2007. Cross-talk between Chk1 and Chk2 in double-mutant thymocytes. Proc. Natl. Acad. Sci. U. S. A. 104:3805-3810.
64. Tho LM, Libertini S, Rampling R, Sansom O, Gillespie DA. 2012. Chk1 is essential for chemical carcinogen-induced mouse skin tumorigenesis.Oncogene 31:1366-1375.
65. Li J, Ng EK, Ng YP, Wong CY, Yu J, Jin H, Cheng VY, Go MY, Cheung PK, Ebert MP, Tong J, To KF, Chan FK, Sung JJ, Ip NY, Leung WK. 2009. Identification of retinoic acid-regulated nuclear matrix-associated protein as a novel regulator of gastric cancer. Br. J. Cancer 101:691-698.
66. Mackintosh C, Ordonez JL, Garcia-Dominguez DJ, Sevillano V, Llombart-Bosch A, Szuhai K, Scotlandi K, Alberghini M, Sciot R, Sinnaeve F,Hogendoorn PC, Picci P, Knuutila S, Dirksen U, Debiec-Rychter M,Schaefer KL, de Alava E. 2012. 1q gain and CDT2 overexpression underlie an aggressive and highly proliferative form of Ewing sarcoma. Oncogene 31:1287-1298.
67. Pan HW, Chou HY, Liu SH, Peng SY, Liu CL, Hsu HC. 2006. Role of L2DTL, cell cycle-regulated nuclear and centrosome protein, in aggressive hepatocellular carcinoma. Cell Cycle 5:2676-2687.
68. Ueki T, Nishidate T, Park JH, Lin ML, Shimo A, Hirata K, Nakamura Y, Katagiri T. 2008. Involvement of elevated expression of multiple cellcycle regulator, DTL/RAMP (denticleless/RA-regulated nuclear matrix associated protein), in the growth of breast cancer cells. Oncogene 27:5672-5683